NEW YORK, May 16, 2025 /PRNewswire/ -- Today, the FDA's approved the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio, marking a pivotal moment in the fight against Alzheimer's disease. This is the first blood test authorized to aid in the diagnosis of Alzheimer's—ushering in a new era of...
Read More Details
Finally We wish PressBee provided you with enough information of ( Statement from the Alzheimer's Drug Discovery Foundation (ADDF) on FDA Approval of the First Blood Test to Aid in Alzheimer's Diagnosis )
Also on site :
- Oscar Winner Stuns On The Red Carpet As The Cannes ‘Godmother’ — What The Prestigious Title Means
- Yet another docu-series about Deion Sanders is currently in the works
- Food Network Star Teases Major Career Venture